Media release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Research
JAMA, Web page
Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference: JAMA Network Open
conference: JAMA Network Open
Research:Paper
Organisation/s:
University of Copenhagen, Denmark
Funder:
The study was supported by the Novo Nordisk Foundation Center (Excellence grant No.
NNF16OC0019968 for basic metabolic research), the Novo Nordisk Foundation Tripartite Immunometabolism (grant No. NNF15CC0018486), Helsefonden, the Faculty of Health and Medical Sciences of the University of
Copenhagen, the Danish Diabetes Academy, and the Department of Biomedical Sciences of the University of Copenhagen. Novo Nordisk A/S supplied Saxenda (liraglutide) and placebo pens, and Cambridge Weight Plan supplied low-calorie meal replacement products